Product Highlight - Zimilast 1000
20 Nov 2020

The Effective Choice
Against ESBL producing MDR pathogens
- Lower respiratory tract infections
- Urinary tract infections
- Intra-abdominal infections
- Gynecologic infections
- Bacterial septicemia
- Bone and joint infections
- Skin and skin structure infections
- Endocarditis
- Polymicrobial infections
Against ESBL producing MDR pathogens
- Lower respiratory tract infections
- Urinary tract infections
- Intra-abdominal infections
- Gynecologic infections
- Bacterial septicemia
- Bone and joint infections
- Skin and skin structure infections
- Endocarditis
- Polymicrobial infections